KBC Group’s Loxo Oncology, Inc LOXO Stock Holding History

KBC Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-87,191	Closed	-$12.2M	–	1461
2018 Q4	$12.2M	Sell	87,191 -38,421	-31%	-$5.83M	0.14%	195
2018 Q3	$21.5M	Buy	125,612 +63,122	+101%	+$10.6M	0.16%	165
2018 Q2	$10.8M	Sell	62,490 -11,771	-16%	-$1.77M	0.09%	266
2018 Q1	$8.57M	Buy	+74,261	New	+$7.9M	0.08%	286

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

KBC Group's LOXO Position: Q1 2019 in Review

KBC Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 87,191 shares — an estimated $12.2M sold.

KBC Group first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $21.5M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

KBC Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
KBC Group sold 87,191 Loxo Oncology, Inc shares in Q1 2019, an estimated $12.2M.
KBC Group first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
KBC Group's Loxo Oncology, Inc position peaked at $21.5M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on KBC Group's 13F filing for Q1 2019, filed 10 May 2019.